Tracking the invisible – biomarkers in mitochondrial disease - Mitochondrial disease research zone - The Lily Foundation - The Lily Foundation
The Lily Foundation logo featuring a butterfly, hearts and an 'x' for a kiss

Fighting mito,
finding hope.

Logo of the Lily Foundation's Research Zone Logo of the Lily Foundation's Research Zone

Research Zone

Welcome to The Lily Foundation’s Research Zone, your gateway to the latest breakthroughs, expert insights and cutting-edge developments in mitochondrial disease research.

Tracking the invisible – biomarkers in mitochondrial disease

Trials hub

4 July 2025

In this post, learn how biomarkers, the body’s early warning signals, can help detect and monitor mitochondrial disease. Discover why they’re essential for tracking disease progression and how the LifeArc Centre for Rare Mitochondrial Diseases is supporting research to develop non-invasive, organ-specific tools for better patient care.

Overhead of a medical professional taking the blood pressure of a patient at a desk

What are biomarkers and why do they matter in mitochondrial disease?

Biomarkers are measurable signals in the body, found in things like blood or tissue, that help us understand how a disease is behaving or responding to treatment.

They’re a bit like the warning lights and gauges on a car dashboard. These don’t just tell you something’s wrong, they help track changes over time. In mitochondrial disease, where many different organs can be affected, this kind of insight is crucial.

Finding biomarkers is a key goal of the LifeArc Centre for Rare Mitochondrial Diseases. Researchers are trying to identify and develop a portfolio of clinically relevant, organ-specific, non-invasive biomarkers for the muscles, heart, brain and eyes.

These biomarkers can help detect mitochondrial disease earlier, monitor how it progresses and assess whether treatments are working, ultimately helping to improve care for people living with these rare conditions.

Find out more in our video explainer below.